USANA Health Sciences Provides Preliminary Second Quarter Results and Updates Fiscal Year 2022 Outlook
07 7월 2022 - 5:05AM
Business Wire
USANA Health Sciences, Inc. (NYSE: USNA) today announced
preliminary results for the second quarter ended July 2, 2022, and
provided an updated outlook for fiscal year 2022. The Company
anticipates that second quarter 2022 net sales will be
approximately $265 million, which compares with $337 million in the
prior-year period. Earnings per share for the quarter are expected
to be approximately $1.05, which compares with $1.87 during the
second quarter of 2021.
“Our sales performance during the second quarter was below
expectations, as COVID-related lockdowns, restrictions, and other
disruptions continued in mainland China and other markets,” said
Kevin Guest, Chief Executive Officer and Chairman of the Board.
“These challenges were particularly disruptive to the regional
sales program we offered in several key markets during the quarter,
and ultimately caused participation in the program, sales results
and active customer counts to come in lower than anticipated.
Importantly, this program was designed to be a catalyst for sales
and customer growth not only during the quarter, but also in the
second half of the year. As a result of this and the continued
uncertainty surrounding the operating environment going forward, we
anticipate softer sales and customer counts in the second half of
the year.”
“We continue to evaluate opportunities in our markets around the
world including promotional and incentive offerings in light of the
operating environment and will make necessary adjustments to
facilitate sales and customer growth going forward. That said, we
remain committed to our established strategic growth objectives,
including: (1) enhancing the digital experience for our customers
to improve the overall online shopping experience; (2) improving
Associate onboarding and training to help drive and sustain
customer growth; (3) exploring additional promotional and incentive
offerings on a market-specific basis; (4) launching experience
centers in mainland China to facilitate our strategic growth plan
for this key market; and (5) pursuing accretive business
development opportunities. We continue to believe that these
objectives remain a critical component to returning USANA to
sustainable future growth.”
Doug Hekking, Chief Financial Officer, said, “As a result of our
first-half performance, and outlook for the remainder of the year,
we now anticipate net sales between $1.015-$1.065 billion and
diluted EPS between $3.85-$4.45. Additionally, inflationary
pressures have persisted across several areas of our business, and
we are continuing to work with our various stakeholders to manage
operating expenses accordingly. Despite current challenges, USANA
remains very profitable and expects to generate strong cash flow in
fiscal year 2022.”
Q2 2022 Preliminary
Results
Revised
Full-Year 2022
Guidance Range
Previous
Full-Year 2022
Guidance Range
Net sales
$265 million
$1.015 - $1.065 billion
$1.100 - $1.200 billion
EPS – diluted
$1.05
$3.85 - $4.45
$5.00 - $5.70
Final results for the second quarter are expected to be released
after the close of market on Tuesday, July 26, 2022. Shortly
following the issuance of the Company’s earnings release, the
Company will post its Management Commentary document on the
Company’s website (http://ir.usana.com) under the Investor
Relations section of the site. USANA will hold a conference call to
discuss this announcement with analysts and institutional investors
the following morning, Wednesday, July 27, 2022, at 11:00 a.m.
Eastern Time. The call will be broadcast over the Internet and can
be accessed at http://ir.usana.com.
The Company’s preliminary financial results and views on market
trends observed in the second quarter of 2022 are based on
information available as of the date of this release.
About USANA
USANA develops and manufactures high-quality nutritional
supplements, healthy foods and personal care products that are sold
directly to Associates and Preferred Customers throughout the
United States, Canada, Australia, New Zealand, Hong Kong, China,
Japan, Taiwan, South Korea, Singapore, Mexico, Malaysia, the
Philippines, the Netherlands, the United Kingdom, Thailand, France,
Belgium, Colombia, Indonesia, Germany, Spain, Romania, and Italy.
More information on USANA can be found at
www.usana.com.
Safe Harbor
This press release contains forward-looking statements within
the meaning of Section 27A of the Securities Act and Section 21E of
the Securities Exchange Act. Our actual results could differ
materially from those projected in these forward-looking
statements, which involve a number of risks and uncertainties,
including: uncertainty related to the magnitude, scope and duration
of the impact of the COVID-19 pandemic (“COVID-19”) to our
business, operations and financial results; the further spread of,
and regulatory measures or voluntary actions that may be put in
place to limit the spread of, COVID-19 in the markets where we
operate, including restrictions on business operations, shelter at
home, or social distancing requirements; the potential for a
resurgence of COVID-19 spread in any of our markets in the future;
the impact of COVID-19 on the domestic and world economies,
including any negative impact on discretionary spending, consumer
demand, and consumer behavior in general; regulatory risk in China
in connection with the health products and direct selling business
models; regulatory risk in the United States in connection with the
direct selling business model; potential negative effects of
deteriorating foreign and/or trade relations between the United
States and China; potential negative effects from geopolitical
relations and conflicts, including the Russia-Ukraine conflict;
potential negative effects of material breaches of our information
technology systems to the extent we experience a material breach;
material failures of our information technology systems; global
economic conditions generally, including increasing inflationary
pressure around the world and any negative impact on our operating
costs, consumer demand and consumer behavior in general; reliance
upon our network of independent Associates; risk associated with
governmental regulation of our products, manufacturing and direct
selling business model; adverse publicity risks globally; risks
associated with our international expansion and operations; and
uncertainty relating to the fluctuation in U.S. and other
international currencies. The contents of this release should be
considered in conjunction with the risk factors, warnings, and
cautionary statements that are contained in our most recent filings
with the Securities and Exchange Commission. The forward-looking
statements in this press release set forth our beliefs as of the
date hereof. We do not undertake any obligation to update any
forward-looking statement after the date hereof or to conform such
statements to actual results or changes in the Company’s
expectations, except as required by law.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220706005730/en/
Investor contact:
Patrique Richards Investor Relations (801) 954-7961
investor.relations@usanainc.com
Media contact:
Dan Macuga Public Relations (801) 954-7280
USANA Health Sciences (NYSE:USNA)
과거 데이터 주식 차트
부터 6월(6) 2024 으로 7월(7) 2024
USANA Health Sciences (NYSE:USNA)
과거 데이터 주식 차트
부터 7월(7) 2023 으로 7월(7) 2024